The medical devices sector is typified by frequent change and innovation, in response to problems and issues faced by the healthcare industry. As a result, the sector has seen the emergence of several start-up medtech companies offering disruptive, cutting-edge solutions. Most of these are private companies, where data such as revenue is frequently not disclosed. National estimates for Reflow Medical sales in the US from 2016 to 2022, as well as year-on-year growth rates, can be viewed in GlobalData’s micro revenue report. Buy the report here.
Reflow Medical is a medical equipment company that designs and develops novel technologies for the treatment of cardiovascular diseases. Its cardiovascular product portfolio includes coraCatheters, for percutaneous coronary intervention; Wingman, a crossing catheter; Spex a shapable support catheter; and spexLP, a reinforced support catheter. It is also developing Reflow spur, a temporary spur stent system. Its devices are designed to be compatible with the physician’s preferred guidewire and technique, enabling treatment of a diverse range of vascular diseases. Reflow Medical is headquartered in San Clemente, California, the US.
The key metrics of Reflow Medical related to marketed and pipeline products, ongoing clinical trials, active jobs and publications from 2022 are shown below:
As Reflow Medical is a privately held company, it is not required to disclose its financial information and there is no stock listed on an exchange. GlobalData has access to a proprietary data set containing invoice data from over 2,600 healthcare institutions in the US and is therefore able to use estimations of a company’s revenue and growth to value private companies such as Reflow Medical.
For a detailed understanding of the performance of Reflow Medical, buy the report here.